À PROPOS DE CET ÉPISODE
Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how the recent approvals fit in the treatment landscape of 2-drug, single-tablet regimens. Stream on the go or follow along with our expert-curated slides.
Topics covered include:
- Guideline recommendations on ART switch in the setting of virologic suppression
- Phase III clinical trial data supporting ART switch
- Individual considerations for ART switch
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.
Presenters:
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom of Great Britain and Northern Ireland
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom
Peter J. Ruane, MD
President
Ruane Clinical Research
Los Angeles, California
Link to program page:
https://bit.ly/3PkPoP4
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
